DeECO

More than 700,000 Pounds Collected at DEA Drug Take Back Day

By DeECO / May 23, 2022 / Comments Off on More than 700,000 Pounds Collected at DEA Drug Take Back Day

Original Post May 23, 2022 Contact: Media Relations Phone Number: (571) 776-2508 DEA and Partners Collected Unneeded Medications in an Effort to Prevent Addiction and Reduce Overdose Deaths  WASHINGTON – On April 30, 2022, communities across the country demonstrated their support for DEA’s annual National Prescription Drug Take Back Day by dropping off more than 720,000 pounds of…

Read More

Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV

By DeECO / May 23, 2022 / Comments Off on Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV

Original Post The EUA authorizes at-home sample collection with testing performed in a laboratory For Immediate Release: May 16, 2022 Today, the U.S. Food and Drug Administration authorized the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription by individuals with symptoms of respiratory viral infection consistent with COVID-19. This product is…

Read More

Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years

By DeECO / May 19, 2022 / Comments Off on Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years

Original Post For Immediate Release: May 17, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with…

Read More

Woodside Acquisitions Inc. Recalls Oral Rapid SARS-CoV-2 Antigen Rapid Test Kits and Joysbio SARS-CoV-2 Antigen Rapid Test Kits (Colloidal Gold) That Are Not Authorized, Cleared, or Approved by the FDA

By DeECO / May 18, 2022 / Comments Off on Woodside Acquisitions Inc. Recalls Oral Rapid SARS-CoV-2 Antigen Rapid Test Kits and Joysbio SARS-CoV-2 Antigen Rapid Test Kits (Colloidal Gold) That Are Not Authorized, Cleared, or Approved by the FDA

Original Post The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Names: Oral Rapid SARS-CoV-2 Antigen Rapid Test Kit and Joysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold) Distribution Dates: January 6, 2022, to January…

Read More

Guidance for Industry: Infant Formula Enforcement Discretion Policy

By DeECO / May 17, 2022 / Comments Off on Guidance for Industry: Infant Formula Enforcement Discretion Policy

Original Post MAY 2022 Download the Final Guidance Document Docket Number: FDA–2022–D–0814 Issued by: Center for Food Safety and Applied Nutrition We are issuing this guidance document to help increase the supply of infant formula in the United States.  FDA intends to temporarily exercise enforcement discretion with respect to certain requirements for infant formulas that…

Read More

FDA Warns Consumers About the Accidental Ingestion by Children of Food Products Containing THC

By DeECO / May 16, 2022 / Comments Off on FDA Warns Consumers About the Accidental Ingestion by Children of Food Products Containing THC

Original Post May 13, 2022 Audience All consumers What is the problem? Edible products containing tetrahydrocannabinol (THC) can be easily mistaken for commonly consumed foods such as breakfast cereal, candy, and cookies, and accidentally ingested.   Accidental ingestion of these products can lead to serious adverse events, especially in children. Some edible products are designed…

Read More

FDA Takes Important Steps to Improve Supply of Infant and Specialty Formula Products

By DeECO / May 12, 2022 / Comments Off on FDA Takes Important Steps to Improve Supply of Infant and Specialty Formula Products

Original Post For Immediate Release: May 10, 2022 Today, the U.S. Food and Drug Administration is providing an update on its work to increase the availability of infant and specialty formula products. On Feb. 17, the agency warned consumers not to use certain powdered infant formula products from Abbott Nutrition’s Sturgis, Michigan facility, and Abbott initiated a voluntary…

Read More

May 10: National Fentanyl Awareness Day

By DeECO / May 11, 2022 / Comments Off on May 10: National Fentanyl Awareness Day

Original Post National Fentanyl Awareness Day aims to amplify nationwide efforts to increase awareness and decrease demand for fentanyl , which is a highly addictive synthetic opioid that continues to drive the overdose epidemic.  “Fentanyl is the single deadliest drug threat our nation has ever encountered,” said Administrator Anne Milgram.  “Fentanyl is everywhere.  From large…

Read More

Do Not Use Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test: FDA Safety Communication

By DeECO / May 11, 2022 / Comments Off on Do Not Use Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test: FDA Safety Communication

Original Post Date Issued: May 10, 2022 The U.S. Food and Drug Administration (FDA) is warning people not to use the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold). This test is not authorized, cleared, or approved by the FDA for distribution or use in the United States. The FDA is concerned about the…

Read More

Is It Really ‘FDA Approved’?

By DeECO / May 10, 2022 / Comments Off on Is It Really ‘FDA Approved’?

Original Post “FDA approved!” Maybe you saw those words on a company’s website or in a commercial promoting a product or treatment. Some marketers may say their products are “FDA approved.” But how can you know for sure what the U.S. Food and Drug Administration has approved? The FDA is responsible for protecting public health…

Read More